Skip to content

Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia

Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01750385
Enrollment
60
Registered
2012-12-17
Start date
2012-10-31
Completion date
2013-08-31
Last updated
2012-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Achalasia

Keywords

Esophageal Achalasia, antibiotic prophylaxis, blood culture, procalcitonin levels

Brief summary

Peroral Endoscopic Myotomy (POEM) is a novel, promising endoscopic technique for achalasia because it is safer and more effective than traditional Heller's myotomy. However, the issue of antibiotic prophylaxis in POEM has evoked considerable controversy recently. Therefore, we conduct this study to elucidate the status of POEM-related bacteremia and procalcitonin levels in order to preliminary observe whether antibiotic prophylaxis is needed.

Detailed description

Objective: To elucidate the status of POEM-related bacteremia and procalcitonin levels in order to preliminary observe whether antibiotic prophylaxis is needed. Interventions: Patients with achalasia diagnosed by symptoms, endoscopy and barium swallow eligible for POEM are randomized to either use antibiotic prophylactically or not. Main outcome measurements: Blood culture positive incidence; secondary outcomes are procalcitonin levels, C-reactive protein levels, white blood cell counts and so on.

Interventions

DRUGno antibiotic prophylaxis

These patients are in no antibiotic prophylaxis group will not be administered antibiotic prophylactically.

DRUGsecond-generation cephalosporin

These patients are in antibiotic prophylaxis group will be administered second-generation cephalosporin prophylactically.

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of esophageal achalasia * Ready to have the treatment as POEM and no contraindication of POEM * Ability to get informed consent

Exclusion criteria

* Patients who had indications for antibiotic prophylaxis as determined by the American Society for Gastrointestinal Endoscopy * Patients who had received antibiotics for any reason within the previous 7days * Patients who had possible signs of any infection at the time of the procedure * Patients who had chronic inflammatory diseases need hormonotherapy : such as rheumatic arthritis or inflammatory bowel diseases.

Design outcomes

Primary

MeasureTime frameDescription
Blood culture positive incidenceafter 12 hours of POEMTo compare the positive incidence of blood cultures between antibiotic prophylaxis and no antibiotic prophylaxis.

Secondary

MeasureTime frameDescription
procalcitonin levelafter 12 hours of POEMTo observe the changes of procalcitonin levels after POEM in which no antibiotic is administered. To compare the procalcitonin levels between antibiotic prophylaxis and no antibiotic prophylaxis.

Other

MeasureTime frameDescription
clinical manifestationduring hospital stay and up to 1 weekTo observe the changes of temperature, heart rate, respiratory rate, white blood cell counts, neutrophile granulocyte counts in perioperative period.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026